Not applicableNot Yet RecruitingNCT06994312
What this trial is testing
The Impact of Nafamostat Mesylate on the Prognosis of Patients With Sepsis-Induced Coagulopathy Undergoing Hemofiltration
Who this might be right for
Sepsis-induced Coagulopathy (SIC)
The First Hospital of Jilin University 282